Effects of High Dose Progestin on Serum Lipids and Lipid Metabolizing Enzymes in Patients with Endometrial Cancer

A. Lehtonen; M. Grönroos; J. Marniemi; P. Peltonen; M. Mäntylä; J. Niskanen; A. Rautio; E. Hietanen

doi:10.1055/s-2007-1013440

Hormone and Metabolic Research, Table of Contents

Horm Metab Res 1985; 17(1): 32-34
DOI: 10.1055/s-2007-1013440

Clinical

Effects of High Dose Progestin on Serum Lipids and Lipid Metabolizing Enzymes in Patients with Endometrial Cancer

A. Lehtonen, M. Grönroos, J. Marniemi, P. Peltonen, M. Mäntylä, J. Niskanen, A. Rautio, E. Hietanen

Departments of Medicine, Obstetrics and Gynecology, University of Turku, The Rehabilitation Research Centre of the Social Insurance Institution, Turku, Department of Pharmacology, University of Oulu, Oulu, Finland

Abstract

PDF Download

Summary

The effect of high dose medroxyprogesterone acetate (MPA) on serum lipids, on adipose tissue lipoprotein lipase (LPL) and serum lecithin cholesterol acyltransferase activities were studied in 15 postmenopausal patients with endometrial cancer. After 2 weeks of MPA treatment total cholesterol decreased by 14% (P < 0.001) and HDL cholesterol by 33% (P < 0.01) from the respective pretreatment values; correspondingly the ratio of HDL to total cholesterol decreased (P < 0.05). The decrease of HDL₂ cholesterol was 35% (P< 0.01) and that of HDL₃ cholesterol 15% (P < 0.01). The levels of serum triglycerides decreased significantly (P < 0.05) during the treatment period. Serum LCAT activity was significantly lower (P < 0.05) after treatment than before, but adipose tissue LPL activity was not altered. The mean serum testosterone level decreased significantly (P < 0.001) from the pretreatment values. Significant positive correlations were present between LPL activity and MPA concentrations and between LPL activity and testosterone concentrations after the drug treatment.

Key-Words:

Progestin - Serum Lipids - Lipid Metabolizing Enzymes

PDF (312 kb)